搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
1 小时
What are your questions about weight loss drugs?
Weight loss and diabetes drugs Ozempic, Wegovy, Mounjaro and Zepbound are seen as game-changers for obesity and weight ...
来自MSN
4 小时
Is Ozempic the modern wonder drug? All the conditions the weight loss jab can tackle ...
We’re using it for fatty liver [disease], high cholesterol, you name it.” Ozempic, Mounjaro, Wegovy, Victoza and Trulicity ...
5 小时
Lars Fruergaard Jørgensen
Lars Fruergaard Jørgensen began his career at Novo Nordisk as an economist in the health care, economy, and planning ...
Healthline
15 小时
Ozempic and Wegovy May Provide Strong Relief from Osteoarthritis Knee Pain
Weight loss drugs like Ozempic and Wegovy may provide strong relief from severe osteoarthritis knee pain, new research finds.
19 小时
on MSN
司美格鲁肽仿制药安全问题曝光:已致10死100人住院,诺和诺德紧急 ...
【ITBEAR】诺和诺德公司近日向美国食品药品监督管理局(FDA)提交申请,请求禁止生产其畅销减肥药Wegovy和Ozempic的仿制药。据公司首席财务官Karsten Munk ...
1 天
Prof Tim Spector leads research to see if Ozempic could beat bowel cancer
Metabolism-targeting injections could pave the way for a new treatments, detection and prevention of bowel cancer ...
1 天
Ozempic and Wegovy could be ‘game changers’ for bowel cancer, as Tim Spector heads research
In what could be a revolutionary stride in cancer care, scientists are exploring metabolism-targeting injections as a ...
WPSD Local 6
1 天
Compounded semaglutide associated with at least 10 deaths, Novo Nordisk CEO warns
Compounded versions of semaglutide, the active ingredient in approved diabetes and obesity drugs Ozempic and Wegovy, have ...
1 天
Novo Nordisk: Be Greedy When Others Are Fearful
Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...
1 天
US Minority Veterans Face Unequal Access to Ozempic and Wegovy, Study Finds
(Reuters) - U.S. military veterans face racial and ethnic inequities in access to Novo Nordisk's highly in-demand drugs for ...
腾讯网
1 天
减肥药致10人死亡100人住院!司美格鲁肽仿制药存安全问题
鉴于此严峻情况,诺和诺德已正式向美国食品药品监督管理局(FDA)提出申请,要求禁止生产Wegovy和Ozempic的仿制药。公司方面强调,这两种药物结构复杂,现有制药商难以确保仿制药的安全性。
1 天
on MSN
司美格鲁肽仿制药安全问题凸显:已致10人丧生,100人住院
【ITBEAR】诺和诺德公司近日向美国食品药品监督管理局(FDA)提交申请,请求禁止生产其畅销减肥药Wegovy和Ozempic的仿制药。据公司首席财务官Karsten Munk ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈